GBI Research, the leading business intelligence provider, has released its latest research: "Solid Tumors in Asia-Pacific Market to 2019 – New and Anticipated Approvals of Targeted Therapies to Trigger a Shift in Treatment Paradigm", which provides in-depth analysis of four key therapeutic indications within the Asia-Pacific (APAC) solid tumors market – bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer – covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116430.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/solid-tumors-market-in-asia-pacific-to-2019-new-drug-approvals-and-anticipated-product-launches-to-trigger-a-shift-in-treatment-paradigm-to-targeted-therapies-market-report.html.
No comments:
Post a Comment